Carterra is a leading provider of innovative technologies designed to accelerate the discovery of novel therapeutic candidates. Carterra’s high throughput LSA™ instrument for monoclonal antibody (mAb) screening and characterization combines patented microfluidics technology with real-time High Throughput Surface Plasmon Resonance (HT-SPR) and industry leading Kinetic and Epitope analysis and visualization software, delivering up to 100 times the throughput in 10% of the time while using only 1% of the sample compared to existing platforms. The LSA provides customers with screening and characterization throughput and functionality that matches the output from state-of-the-art antibody expression platforms. This enables all antibodies to be rapidly and comprehensively screened early in the discovery process so that unique epitopes and potential novel therapeutic candidates can be identified, while expanding and enhancing IP coverage. The Carterra LSA condenses months of work into a few days.
Salt Lake City, Utah, United States
Find 62 technologies across 16 categories used by Carterra
Find rich insights on prospects from Carterra including contact information, interests,skills and more
Josh Eckman is Chief Executive Officer at Carterra at Utah United States...
Find recent and open job postings from Carterra
Get news, alerts, and updates about Carterra
We don't have enough content for Carterra company news and alerts.
The official website of Carterra is https://carterra-bio.com/.
The phone number for Carterra is 4802474400.
Slintel keeps track of 51-200 employees who are working at Carterra.
Carterra is in the industry of Biotechnology.
The top technologies used by Carterra are :- Tableau Software HubSpot CRM reCAPTCHA Acumatica ON24 Tableau Software .
Carterra headquarters are at Salt Lake City, Utah, United States.
Carterra's product and services are biotechnology antibody discovery label-free epitope binning kinetic characterization SPR epitope mapping cancer neuroscience infectious disease immunooncology antibody development B-Cell Enrichment phage display protein-protein hybridoma B Cell Cloning covid19 immunity monitoring vaccine research serology hybridoma screening .